Biochemical Mechanisms of Antibiotic Resistance: From β-Lactamases to Efflux Pumps

Background: The global escalation of antibiotic resistance poses a profound threat to public health, undermining decades of progress in infectious disease management. At the core of this crisis lie diverse and rapidly evolving biochemical mechanisms that bacteria employ to evade the action of antibiotics. These include enzymatic degradation, target modification, membrane permeability alteration, and active drug efflux. Understanding these molecular strategies is essential for developing novel therapeutics and diagnostic tools to combat resistant pathogens. Methods and Results: This review delineates the major biochemical classes of resistance mechanisms with an emphasis on β-lactamases, aminoglycoside-modifying enzymes, target-protecting proteins, and multidrug efflux pumps. β-lactamases, such as class A TEM and class B metallo-β-lactamases, hydrolyze the β-lactam ring, rendering penicillins and carbapenems ineffective. Ribosomal methyltransferases and gyrase-protecting Qnr proteins exemplify target modification strategies. Efflux pumps like AcrAB-TolC and MexAB-OprM actively expel diverse antibiotic classes, contributing to multidrug resistance phenotypes. Regulatory networks, such as two-component systems and quorum sensing pathways, further modulate resistance gene expression in response to environmental stimuli. Structural and kinetic studies have illuminated active site features and substrate profiles, informing inhibitor design. Emerging approaches, including CRISPR-based genome editing and efflux pump inhibitors, offer promising strategies to restore antibiotic susceptibility. Conclusion: A mechanistic biochemical understanding of antibiotic resistance provides critical insight into the adaptive resilience of pathogenic bacteria. By targeting enzymatic and regulatory nodes within resistance pathways, next-generation antimicrobials and adjuvants can be rationally developed to outpace bacterial evolution and preserve the efficacy of existing drug arsenals.